Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 3
2004 2
2005 2
2006 2
2007 6
2008 22
2009 12
2010 11
2011 12
2012 13
2013 7
2014 5
2015 11
2016 6
2017 2
2018 10
2019 9
2020 14
2021 15
2022 13
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Results by year

Filters applied: . Clear all
Page 1
Longitudinal assessment of tumor-infiltrating lymphocytes in primary breast cancer following neoadjuvant radiotherapy.
Yoneyama M, Zormpas-Petridis K, Robinson R, Sobhani F, Provenzano E, Steel H, Lightowlers S, Towns C, Castillo SP, Anbalagan S, Lund T, Wennerberg E, Melcher A, Coles CE, Roxanis I, Yuan Y, Somaiah N. Yoneyama M, et al. Among authors: melcher a. Int J Radiat Oncol Biol Phys. 2024 Apr 26:S0360-3016(24)00566-2. doi: 10.1016/j.ijrobp.2024.04.065. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 38677525
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference.
Gregucci F, Spada S, Barcellos-Hoff MH, Bhardwaj N, Chan Wah Hak C, Fiorentino A, Guha C, Guzman ML, Harrington K, Herrera FG, Honeychurch J, Hong T, Iturri L, Jaffee E, Karam SD, Knott SRV, Koumenis C, Lyden D, Marciscano AE, Melcher A, Mondini M, Mondino A, Morris ZS, Pitroda S, Quezada SA, Santambrogio L, Shiao S, Stagg J, Telarovic I, Timmerman R, Vozenin MC, Weichselbaum R, Welsh J, Wilkins A, Xu C, Zappasodi R, Zou W, Bobard A, Demaria S, Galluzzi L, Deutsch E, Formenti SC. Gregucci F, et al. Among authors: melcher a. Oncoimmunology. 2023 Jun 21;12(1):2222560. doi: 10.1080/2162402X.2023.2222560. eCollection 2023. Oncoimmunology. 2023. PMID: 37363104 Free PMC article. Review.
Efficacy of coxsackievirus A21 against drug-resistant neoplastic B cells.
Holmes M, Scott GB, Heaton S, Barr T, Askar B, Müller LME, Jennings VA, Ralph C, Burton C, Melcher A, Hillmen P, Parrish C, Errington-Mais F. Holmes M, et al. Among authors: melcher a. Mol Ther Oncolytics. 2023 Mar 24;29:17-29. doi: 10.1016/j.omto.2023.03.002. eCollection 2023 Jun 15. Mol Ther Oncolytics. 2023. PMID: 37077714 Free PMC article.
Corrigendum to "Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers": Translational Oncology 2022 Nov; 25:101511.
Korlimarla A, Hari PS, Prabhu J, Ragulan C, Patil Y, Snijesh VP, Desai K, Mathews A, Appachu S, Diwakar RB, Srinath BS, Melcher A, Cheang M, Sadanandam A. Korlimarla A, et al. Among authors: melcher a. Transl Oncol. 2023 Jan;27:101574. doi: 10.1016/j.tranon.2022.101574. Epub 2022 Nov 3. Transl Oncol. 2023. PMID: 36517200 Free PMC article. No abstract available.
PEARLS - A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA-avid pelvic and/or para-aortic lymph nodes at presentation.
Murray J, Cruickshank C, Bird T, Bell P, Braun J, Chuter D, Ferreira MR, Griffin C, Hassan S, Hujairi N, Melcher A, Miles E, Naismith O, Panades M, Philipps L, Reid A, Rekowski J, Sankey P, Staffurth J, Syndikus I, Tree A, Wilkins A, Hall E; PEARLS Trial Management Group. Murray J, et al. Among authors: melcher a. Clin Transl Radiat Oncol. 2022 Sep 24;37:130-136. doi: 10.1016/j.ctro.2022.09.003. eCollection 2022 Nov. Clin Transl Radiat Oncol. 2022. PMID: 36238579 Free PMC article.
176 results